Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02294162
Other study ID # 0104-14
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date April 1, 2015
Est. completion date October 1, 2017

Study information

Verified date October 2018
Source Western Galilee Hospital-Nahariya
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pain is an unpleasant sensory experience associated with actual or potential tissue damage. Acute pain management is an important aspect of perioperative anesthetic care. Moreover, it is the most important factor related to patient discomfort after surgery. Adequate pain management, ideally resulting in the complete absence of postoperative pain, not only provides comfort to patients, but may also contribute to improved healing and a reduction in the incidence of postoperative complications. Inadequate postoperative analgesia has been shown to contribute to adverse outcomes, including, but not limited to, immunosuppression, hyperglycemia, poor rehabilitation, and progression to chronic pain.


Description:

Patients who are scheduled for submucosal resection of nasal septum with or without turbinectomy will be recruited for the study The patients will be will be assigned to either the treatment group who will be administered ketamine prior to the operation or the control group who will receive a normal saline injection, both in identicle syringes.

All patients will be operated on by the same surgoens and by the same method of dissection and hemostasis (2-5 2 ml lidocadrain carpules, monopolar suction-cautery set on 25).

Patients folow-up will be reported in their medical charts. The post operative analgetic effect will be assessed by the amount of analgesia required in the post-operative period and by regular pain measurements using VAS (Visual Analogue Scale) - at 0.5 hours post operation in the recovery room, 8 hours post operation and the morning of first post operative day in the otolaryngology - head and neck department


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date October 1, 2017
Est. primary completion date October 1, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria:

- Patients undergoing submucosal resection of nasal septum with or without turbinectomy.

- Over 18 years of age.

- ASA (anesthsiology Severity Score) score of 1-2.

- Signed informed consent by patient or caregiver.

Exclusion Criteria:

- Allergy to Ketamine

- Unable/ unwilling to comply with the protocol requirements

- Pregnancy or breast feeding

- Chronic use of analgetics

- History of alcohol and/or drug abuse

- Previous nasal surgry

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Ketamine i.v


Locations

Country Name City State
Israel Galillee medical center Naharia

Sponsors (1)

Lead Sponsor Collaborator
Western Galilee Hospital-Nahariya

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain: reduction in severity based on VAS score. The post operative analgetic effect will be assessed by the amount of analgesia required in the post-operative period and by regular pain measurements using VAS (Visual Analogue Scale) - at 0.5 hours post operation in the recovery room, 8 hours post operation and the morning of first post operative day the morning of first post operative day
Primary consumption of postoperative pain medication type, dosage and reduction in the demand postoperatively. The data will be collected from the medical file the morning of first post operative day
Secondary Readmission for any reason. one week
Secondary Duration of hospital stay. one week
See also
  Status Clinical Trial Phase
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Recruiting NCT04228016 - Efficacy of an Intranasal Stent on Nasal Obstruction at Night N/A
Completed NCT02914236 - Treatment of Nasal Airway Obstruction Using the Aerin Medical Device N/A
Completed NCT02952313 - Spirox Lateraâ„¢ Implant Support of Lateral Nasal Wall Cartilage (LATERAL-OR) Study N/A
Completed NCT01965457 - Assessment of Adenoidal Obstruction in Children : Clinical Signs Versus Flexible Nasal Endoscopy and Roentgenographic Findings N/A
Completed NCT00850876 - Heated Humidified Continuous Positive Airway Pressure and Nasal Physiology N/A
Completed NCT03156270 - Treatment Outcome Using Vivaer Stylus to Treat Nasal Airway Obstruction N/A
Active, not recruiting NCT05099263 - The Vivaer Procedure for Treatment of the Septal Swell Bodies (SWELL) N/A
Recruiting NCT05573919 - VivAer: A Correlation Between Symptom Scores and Objective Findings N/A
Completed NCT03290300 - Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device
Recruiting NCT04499469 - The Role of Spreader Grafts in Reduction Rhinoseptoplasty: a Randomized Clinical Trial With Quality of Life Assessment N/A
Not yet recruiting NCT01702103 - Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays Phase 3
Completed NCT04220853 - Changes in Nasal Airflow Parameters After Septoplasty and Turbinoplasty N/A
Completed NCT03456115 - A New Treatment for Mechanical Nasal Obstruction N/A
Completed NCT00793117 - The Effect of Packing in Post Operative Management of FESS Phase 4
Completed NCT02964312 - LATERA-OFFICE Study N/A
Recruiting NCT04150783 - Computational Modeling of Cleft Lip Nasal Deformity and Assessment of Nasal Function and Treatment Outcomes
Completed NCT01506583 - Clinical Evaluation of QFlu Combo Test
Recruiting NCT03925389 - Outcome Analysis in Septorhinoplasty
Recruiting NCT05494346 - Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction N/A